BIOPLUS ACQUISITION CORP. Financial Statements (2025 and earlier)
Company Profile
| Business Address |
260 MADISON AVENUE, SUITE 800 NEW YORK, NY 10016 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 35,371 | 140,302 | 107,073 | 294,693 | 442,722 | ||||
| Cash and cash equivalent | 35,371 | 140,302 | 107,073 | 294,693 | 442,722 | ||||
| Prepaid expense | 411,773 | 408,461 | 521,483 | 420,845 | 374,417 | ||||
| Total current assets: | 447,144 | 548,763 | 628,556 | 715,538 | 817,139 | ||||
| Noncurrent Assets | |||||||||
| Prepaid expense | 156,464 | 308,472 | |||||||
| Asset, held-in-trust | 240,372,461 | 237,775,823 | 235,883,906 | 234,934,407 | 234,654,062 | ||||
| Total noncurrent assets: | 240,372,461 | 237,775,823 | 235,883,906 | 235,090,871 | 234,962,534 | ||||
| TOTAL ASSETS: | 240,819,605 | 238,324,586 | 236,512,462 | 235,806,409 | 235,779,673 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 226,130 | 263,150 | 288,453 | 241,531 | 198,545 | ||||
| Accrued liabilities | 226,130 | 263,150 | 288,453 | 241,531 | 198,545 | ||||
| Debt | |||||||||
| Due to related parties | ✕ | 474,400 | 263,725 | 3,671 | |||||
| Other undisclosed current liabilities | 37,500 | ||||||||
| Total current liabilities: | 700,530 | 526,875 | 288,453 | 241,531 | 239,716 | ||||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 14,800,000 | 14,800,000 | 14,800,000 | 14,800,000 | 14,800,000 | ||||
| Total noncurrent liabilities: | 14,800,000 | 14,800,000 | 14,800,000 | 14,800,000 | 14,800,000 | ||||
| Total liabilities: | 15,500,530 | 15,326,875 | 15,088,453 | 15,041,531 | 15,039,716 | ||||
| Temporary equity, including noncontrolling interest | 240,372,461 | 237,775,823 | 235,883,906 | 234,934,407 | 234,600,000 | ||||
| Equity | |||||||||
| Equity, attributable to parent, including: | (15,053,386) | (14,778,112) | (14,459,897) | (14,169,529) | (13,860,043) | ||||
| Accumulated deficit | (15,054,017) | (14,778,743) | (14,460,528) | (14,170,160) | (13,860,674) | ||||
| Other undisclosed equity, attributable to parent | 631 | 631 | 631 | 631 | 631 | ||||
| Total equity: | (15,053,386) | (14,778,112) | (14,459,897) | (14,169,529) | (13,860,043) | ||||
| TOTAL LIABILITIES AND EQUITY: | 240,819,605 | 238,324,586 | 236,512,462 | 235,806,409 | 235,779,673 | ||||
Income Statement (P&L) (USD)Annual | Quarterly
| 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (1,025,000) | |||||||
| Other undisclosed operating income (loss) | 749,726 | (318,215) | (290,368) | (255,424) | (307,189) | |||
| Operating loss: | (275,274) | (318,215) | (290,368) | (255,424) | (307,189) | |||
| Nonoperating income (Investment Income, Nonoperating) | 2,596,638 | 1,891,917 | 949,499 | 280,345 | 45,367 | |||
| Income (loss) from continuing operations: | 2,321,364 | 1,573,702 | 659,131 | 24,921 | (261,822) | |||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 659,131 | 24,921 | (261,822) | ✕ | |
| Net income (loss) available to common stockholders, diluted: | 2,321,364 | 1,573,702 | 659,131 | 24,921 | (261,822) | |||
Comprehensive Income (USD)Annual | Quarterly
| 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 2,321,364 | 1,573,702 | 659,131 | 24,921 | (261,822) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | 2,321,364 | 1,573,702 | 659,131 | 24,921 | (261,822) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.